Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 1/2021

01-02-2021 | Liver Resection | Original Article

Post-hepatectomy liver failure after hepatic resection for hepatocellular carcinoma: a single center experience

Authors: Ahmed Shehta, Ahmed Farouk, Amgad Fouad, Ahmed Aboelenin, Ahmed Nabieh Elghawalby, Rami Said, Mohamed Elshobary, Ayman El Nakeeb

Published in: Langenbeck's Archives of Surgery | Issue 1/2021

Login to get access

Abstract

Purpose

Post-hepatectomy liver failure (PHLF) is one of the most feared morbidities after liver resection (LR) for hepatocellular carcinoma (HCC). We aimed to investigate the incidence and predictors of PHLF after LR for HCC and its impact on survival outcomes.

Methods

We reviewed the patients who underwent LR for HCC during the period between January 2010 and 2019.

Results

Two hundred sixty-eight patients were included. Patients were divided into two groups according to the occurrence of PHLF, defined according to ISGLS. The non-PHLF group included 138 patients (51.5%), while the PHLF group included 130 patients (48.5%). Two hundred forty-six patients (91.8%) had hepatitis C virus. Major liver resections were more performed in the PHLF group (40 patients (30.8%) vs. 18 patients (13%), p = 0.001). Longer operation time (3 vs. 2.5 h, p = 0.001), more blood loss (1000 vs. 500 cc, p = 0.001), and transfusions (81 patients (62.3%) vs. 52 patients (37.7%), p = 0.001) occurred in PHLF group. The 1-, 3-, and 5-year Kaplan-Meier overall survival rates for the non-PHLF group were 93.9%, 79.5%, and 53.9% and 73.2%, 58.7%, and 52.4% for the PHLF group, respectively (log rank, p = 0.003). The 1-, 3-, and 5-year Kaplan-Meier disease-free survival rates for the non-PHLF group were 77.7%, 42.5%, and 29.4%, and 73.3%, 42.9%, and 25.3% for the PHLF group, respectively (log rank, p = 0.925). Preoperative albumin, bilirubin, INR, and liver cirrhosis were significant predictors of PHLF in the logistic regression analysis.

Conclusion

Egyptian patients with HCC experienced higher PHLF incidence after LR for HCC. PHLF significantly affected the long-term survival of those patients.
Literature
1.
go back to reference Ghouri YA, Mian I, Rowe JH (2017) Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinogenesis 16:1 Ghouri YA, Mian I, Rowe JH (2017) Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinogenesis 16:1
2.
go back to reference El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365:1118–1127PubMed El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365:1118–1127PubMed
3.
go back to reference Sherman M (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 24:143–154 Sherman M (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 24:143–154
4.
go back to reference Waked I, Esmat G, Elsharkawy A, el-Serafy M, Abdel-Razek W, Ghalab R, Elshishiney G, Salah A, Abdel Megid S, Kabil K, el-Sayed MH, Dabbous H, el Shazly Y, Abo Sliman M, Abou Hashem K, Abdel Gawad S, el Nahas N, el Sobky A, el Sonbaty S, el Tabakh H, Emad E, Gemeah H, Hashem A, Hassany M, Hefnawy N, Hemida AN, Khadary A, Labib K, Mahmoud F, Mamoun S, Marei T, Mekky S, Meshref A, Othman A, Ragab O, Ramadan E, Rehan A, Saad T, Saeed R, Sharshar M, Shawky H, Shawky M, Shehata W, Soror H, Taha M, Talha M, Tealaab A, Zein M, Hashish A, Cordie A, Omar Y, Kamal E, Ammar I, AbdAlla M, el Akel W, Doss W, Zaid H (2020) Screening and treatment program to eliminate hepatitis C in Egypt. N Engl J Med 382(12):1166–1174PubMed Waked I, Esmat G, Elsharkawy A, el-Serafy M, Abdel-Razek W, Ghalab R, Elshishiney G, Salah A, Abdel Megid S, Kabil K, el-Sayed MH, Dabbous H, el Shazly Y, Abo Sliman M, Abou Hashem K, Abdel Gawad S, el Nahas N, el Sobky A, el Sonbaty S, el Tabakh H, Emad E, Gemeah H, Hashem A, Hassany M, Hefnawy N, Hemida AN, Khadary A, Labib K, Mahmoud F, Mamoun S, Marei T, Mekky S, Meshref A, Othman A, Ragab O, Ramadan E, Rehan A, Saad T, Saeed R, Sharshar M, Shawky H, Shawky M, Shehata W, Soror H, Taha M, Talha M, Tealaab A, Zein M, Hashish A, Cordie A, Omar Y, Kamal E, Ammar I, AbdAlla M, el Akel W, Doss W, Zaid H (2020) Screening and treatment program to eliminate hepatitis C in Egypt. N Engl J Med 382(12):1166–1174PubMed
5.
go back to reference Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMed Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMed
6.
go back to reference Yao FY, Bass NM, Nikolai B (2002) Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 8:873–883PubMed Yao FY, Bass NM, Nikolai B (2002) Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 8:873–883PubMed
7.
go back to reference Shehta A, Han HS, Yoon YS, Cho JY, Choi Y (2016) Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single center experience. Surg Endosc 30(2):638–648PubMed Shehta A, Han HS, Yoon YS, Cho JY, Choi Y (2016) Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single center experience. Surg Endosc 30(2):638–648PubMed
8.
go back to reference Arii S, Yamaoka Y, Futagawa S et al (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32:1224–1229PubMed Arii S, Yamaoka Y, Futagawa S et al (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32:1224–1229PubMed
9.
go back to reference Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–407PubMedPubMedCentral Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–407PubMedPubMedCentral
10.
go back to reference Fukushima K, Fukumoto T, Kuramitsu K, Kido M, Takebe A, Tanaka M, Itoh T, Ku Y (2014) Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg 18(4):729–736PubMed Fukushima K, Fukumoto T, Kuramitsu K, Kido M, Takebe A, Tanaka M, Itoh T, Ku Y (2014) Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg 18(4):729–736PubMed
11.
go back to reference Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S (2008) Short and long-term outcome after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol 15:1670–1676PubMed Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S (2008) Short and long-term outcome after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol 15:1670–1676PubMed
12.
go back to reference Okumura Y, Takeda S, Fujii T et al (2011) Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. J Surg Oncol 104:814–821 Okumura Y, Takeda S, Fujii T et al (2011) Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. J Surg Oncol 104:814–821
13.
go back to reference Chok KS, Ng KK, Poon RT, Lo CM, Fan ST (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87PubMed Chok KS, Ng KK, Poon RT, Lo CM, Fan ST (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87PubMed
14.
go back to reference Wolters U, Wolf T, Stutzer H, Schroder T (1996) ASA classification and perioperative variables as predictors of postoperative outcomes. Br J Anaesth 77:217–222PubMed Wolters U, Wolf T, Stutzer H, Schroder T (1996) ASA classification and perioperative variables as predictors of postoperative outcomes. Br J Anaesth 77:217–222PubMed
15.
go back to reference Wahab MA, Shehta A, Hamed H, El Nakeeb A, Salah T (2014) Predictors of recurrence in hepatitis C virus related hepatocellular carcinoma after hepatic resection: a retrospective cohort study. Eurasian J Med 46(1):36–41PubMedPubMedCentral Wahab MA, Shehta A, Hamed H, El Nakeeb A, Salah T (2014) Predictors of recurrence in hepatitis C virus related hepatocellular carcinoma after hepatic resection: a retrospective cohort study. Eurasian J Med 46(1):36–41PubMedPubMedCentral
16.
go back to reference Abdel-Wahab M, El-Husseiny TS, El Hanafy E, El Shobary M, Hamdy E (2010) Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. Langenbeck’s Arch Surg 395(6):625–632 Abdel-Wahab M, El-Husseiny TS, El Hanafy E, El Shobary M, Hamdy E (2010) Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. Langenbeck’s Arch Surg 395(6):625–632
17.
go back to reference Terminology Committee of the International Hepato-Pancreato- Biliary Association (2000) The IHPBA Brisbane 2000 terminology of liver anatomy and resections. HPB Surg 2:333–339 Terminology Committee of the International Hepato-Pancreato- Biliary Association (2000) The IHPBA Brisbane 2000 terminology of liver anatomy and resections. HPB Surg 2:333–339
18.
go back to reference Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724PubMed Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724PubMed
19.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedPubMedCentral
20.
go back to reference Koch M, Garden OJ, Padbury R et al (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149:680–688PubMed Koch M, Garden OJ, Padbury R et al (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149:680–688PubMed
21.
go back to reference Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, Hugh TJ, Fan ST, Nimura Y, Figueras J, Vauthey JN, Rees M, Adam R, DeMatteo RP, Greig P, Usatoff V, Banting S, Nagino M, Capussotti L, Yokoyama Y, Brooke-Smith M, Crawford M, Christophi C, Makuuchi M, Büchler MW, Weitz J (2011) Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB 13(8):528–535PubMedPubMedCentral Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, Hugh TJ, Fan ST, Nimura Y, Figueras J, Vauthey JN, Rees M, Adam R, DeMatteo RP, Greig P, Usatoff V, Banting S, Nagino M, Capussotti L, Yokoyama Y, Brooke-Smith M, Crawford M, Christophi C, Makuuchi M, Büchler MW, Weitz J (2011) Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB 13(8):528–535PubMedPubMedCentral
22.
go back to reference Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, Khoby TE, Abdel-Wahab Y, Ohn ESA, Anwar W, Sallam I (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887–891PubMed Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, Khoby TE, Abdel-Wahab Y, Ohn ESA, Anwar W, Sallam I (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887–891PubMed
23.
go back to reference Freeman A, Dore GJ, Law MG et al (2001) Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 34:809–816PubMed Freeman A, Dore GJ, Law MG et al (2001) Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 34:809–816PubMed
24.
go back to reference Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL (1999) Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90:42–53PubMed Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL (1999) Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90:42–53PubMed
25.
go back to reference Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46PubMed Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46PubMed
26.
go back to reference Casaccia M, Andorno E, Domenico SD, Nardi I, Bottino G, Gelli M, Valente U (2011) Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients. Feasibility of nonanatomic resection in difficult tumor locations. J Minim Access Surg 7(4):222–226PubMedPubMedCentral Casaccia M, Andorno E, Domenico SD, Nardi I, Bottino G, Gelli M, Valente U (2011) Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients. Feasibility of nonanatomic resection in difficult tumor locations. J Minim Access Surg 7(4):222–226PubMedPubMedCentral
27.
go back to reference Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J (1999) Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229:210–215PubMedPubMedCentral Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J (1999) Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229:210–215PubMedPubMedCentral
28.
go back to reference Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971PubMed Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971PubMed
29.
go back to reference Dinant S, de Graaf W, Verwer BJ, Bennink RJ, van Lienden KP, Gouma DJ, van Vliet AK, van Gulik TM (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685–692PubMed Dinant S, de Graaf W, Verwer BJ, Bennink RJ, van Lienden KP, Gouma DJ, van Vliet AK, van Gulik TM (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685–692PubMed
30.
go back to reference Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854–862PubMed Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN (2007) Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854–862PubMed
31.
go back to reference Elshoubary M, Shehta A, Salah T, Sultan AM, Yassen AM, Abdulrazek M, el-Magd EA, Elghawalby AN, Shiha U, Elmorshedi M, Elsadany M, Abdelkhalek E, Fathy O, Wahab MA (2018) Predictive factors of liver dysfunction after right hemihepatectomy for adult living donor liver transplantation. Transplant Proc 50(4):1114–1122PubMed Elshoubary M, Shehta A, Salah T, Sultan AM, Yassen AM, Abdulrazek M, el-Magd EA, Elghawalby AN, Shiha U, Elmorshedi M, Elsadany M, Abdelkhalek E, Fathy O, Wahab MA (2018) Predictive factors of liver dysfunction after right hemihepatectomy for adult living donor liver transplantation. Transplant Proc 50(4):1114–1122PubMed
32.
go back to reference Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, Seo S, Machimoto T, Uemoto S (2007) Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery 142(5):685–694PubMed Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, Seo S, Machimoto T, Uemoto S (2007) Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery 142(5):685–694PubMed
33.
go back to reference Poon RTP, Fan ST, Ng IOL, Lo CM, Liu CL, Wong J (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500–507PubMed Poon RTP, Fan ST, Ng IOL, Lo CM, Liu CL, Wong J (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500–507PubMed
34.
go back to reference Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207PubMed Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207PubMed
35.
go back to reference Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M (2007) Staging of hepatocellular carcinoma—assessment of the Japanese TNM and AICCIUICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909–922PubMedPubMedCentral Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M (2007) Staging of hepatocellular carcinoma—assessment of the Japanese TNM and AICCIUICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245:909–922PubMedPubMedCentral
36.
go back to reference Pinto A, Hobeika C, Philis A, Kirzin S, Carrère N, Ghouti L (2019) Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? Langenbeck’s Arch Surg 404(4):477–488 Pinto A, Hobeika C, Philis A, Kirzin S, Carrère N, Ghouti L (2019) Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? Langenbeck’s Arch Surg 404(4):477–488
37.
go back to reference Lurje G, Bednarsch J, Czigany Z, Amygdalos I, Meister F, Schöning W, Ulmer TF, Foerster M, Dejong C, Neumann UP (2018) Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent. Langenbeck’s Arch Surg 403(7):851–861 Lurje G, Bednarsch J, Czigany Z, Amygdalos I, Meister F, Schöning W, Ulmer TF, Foerster M, Dejong C, Neumann UP (2018) Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent. Langenbeck’s Arch Surg 403(7):851–861
38.
go back to reference Iguchi K, Hatano E, Yamanaka K, Tanaka S, Taura K, Uemoto S (2014) The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma. World J Surg 38(1):150–158PubMed Iguchi K, Hatano E, Yamanaka K, Tanaka S, Taura K, Uemoto S (2014) The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma. World J Surg 38(1):150–158PubMed
39.
go back to reference Tilg H, Kaser A, Moschen AR (2006) How to modulate inflammatory cytokines in liver diseases. Liver Int 26:1029–1039PubMed Tilg H, Kaser A, Moschen AR (2006) How to modulate inflammatory cytokines in liver diseases. Liver Int 26:1029–1039PubMed
40.
go back to reference Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989–5005PubMed Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989–5005PubMed
41.
go back to reference Barton JS, Riha GM, Differding JA, Underwood SJ, Curren JL, Sheppard BC, Pommier RF, Orloff SL, Schreiber MA, Billingsley KG (2013) Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford) 15(11):865–871 Barton JS, Riha GM, Differding JA, Underwood SJ, Curren JL, Sheppard BC, Pommier RF, Orloff SL, Schreiber MA, Billingsley KG (2013) Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford) 15(11):865–871
42.
go back to reference Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F (2005) The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828PubMedPubMedCentral Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F (2005) The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828PubMedPubMedCentral
43.
go back to reference Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF (2011) Risk factors influencing postoperative outcomes ofmajor hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082PubMed Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF (2011) Risk factors influencing postoperative outcomes ofmajor hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082PubMed
Metadata
Title
Post-hepatectomy liver failure after hepatic resection for hepatocellular carcinoma: a single center experience
Authors
Ahmed Shehta
Ahmed Farouk
Amgad Fouad
Ahmed Aboelenin
Ahmed Nabieh Elghawalby
Rami Said
Mohamed Elshobary
Ayman El Nakeeb
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 1/2021
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-020-01956-2

Other articles of this Issue 1/2021

Langenbeck's Archives of Surgery 1/2021 Go to the issue